ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,180.74
0.00%
Dow Jones
38,852.27
0.00%
US Dollar vs MXN
16.8533
-0.19%
Brent Oil
82.445
-1.23%
Bitcoin
63,571.37
0.64%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Societal CDMO Inc (SCTL)

  7. Societal CDMO Inc (SCTL) Noticias

SCTL Societal CDMO Inc

1.10
0.00 (0.00%)
Pre Mercado
Última actualización: 19:00:00
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Societal CDMO Inc SCTL NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 1.10 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.10
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
08/4/202415:05GLOBECoreRx, Inc. Completes Acquisition of Societal CDMO, Inc.
08/4/202409:10BWCoreRx, Inc. Completes Acquisition of Societal CDMO, Inc.
11/3/202416:04EDGAR2Form SC 14D9 - Solicitation, recommendation statements
11/3/202415:05EDGAR2Form SC TO-T - Tender offer statement by Third Party
06/3/202416:11EDGAR2Form SC 13D - General statement of acquisition of beneficial..
29/2/202416:18EDGAR2Form SC14D9C - Written communication relating to third party..
28/2/202416:27EDGAR2Form SC14D9C - Written communication relating to third party..
28/2/202416:18EDGAR2Form SC14D9C - Written communication relating to third party..
28/2/202415:58EDGAR2Form 8-K - Current report
28/2/202415:29GLOBESocietal CDMO Enters Into Definitive Agreement to be..
01/2/202406:00GLOBESocietal CDMO and Benuvia Sign Co-Marketing Agreement..
05/1/202415:05GLOBESocietal CDMO Reports Inducement Grants for New Staff
28/11/202315:14EDGAR2Form 8-K - Current report
08/11/202315:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202315:11EDGAR2Form 8-K - Current report
08/11/202315:05GLOBESocietal CDMO Reports Third Quarter 2023 Financial Results
01/11/202315:05GLOBESocietal CDMO to Report Financial Results for Third Quarter..
05/10/202315:05GLOBESocietal CDMO Reports Inducement Grants for New Staff
25/9/202315:05GLOBESocietal CDMO to Participate in RBC Capital Markets Virtual..
20/9/202315:10EDGAR2Form 8-K - Current report
20/9/202315:05GLOBESocietal CDMO Announces Corporate Restructuring
07/9/202306:00GLOBESocietal CDMO Secures Project Expansion Agreements With..
29/8/202306:00GLOBESocietal CDMO Announces Closing of $8.3 Million Public..
28/8/202315:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/8/202315:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/8/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202315:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202315:22EDGAR2Form 3 - Initial statement of beneficial ownership of..
25/8/202315:18EDGAR2Form SC 13D - General statement of acquisition of beneficial..
24/8/202306:30GLOBESocietal CDMO Announces Pricing of $8.3 Million Public..
23/8/202315:38EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
23/8/202315:13EDGAR2Form 8-K - Current report
23/8/202315:04GLOBESocietal CDMO Announces Appointment of Matt Arens to Board..
23/8/202315:04GLOBESocietal CDMO Announces Proposed Public Offering of Common..
14/8/202316:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202315:28EDGAR2Form 8-K - Current report
14/8/202315:05GLOBESocietal CDMO Reports Second Quarter 2023 Financial Results
09/8/202306:00GLOBESocietal CDMO Reschedules Second Quarter 2023 Financial..
07/8/202314:27EDGAR2Form SC 13G - Statement of acquisition of beneficial..
02/8/202315:05GLOBESocietal CDMO to Report Financial Results for Second Quarter..
26/7/202306:00GLOBESocietal CDMO Announces Expansion of Controlled Substance..
10/7/202306:00GLOBESocietal CDMO Selected by Spinnaker Biosciences to Provide..
07/7/202315:05GLOBESocietal CDMO Reports Inducement Grants for New Staff
29/6/202306:00GLOBESocietal CDMO Signs Master Service Agreement With..
23/5/202306:00GLOBESocietal CDMO Enters Agreement With Atossa Therapeutics to..
10/5/202315:05GLOBESocietal CDMO Reports First Quarter 2023 Financial Results
09/5/202315:05GLOBESocietal CDMO to Participate in RBC Capital Markets Global..
08/5/202306:00GLOBESocietal CDMO Selected by Xequel Bio to Provide CDMO..

Su Consulta Reciente

NASDAQ
SCTL
Societal CDMO
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados